Why is Sanofi India falling/rising?

As of 10-Sep, Sanofi India Ltd's stock price is currently at 5,070.95, reflecting an increase of 30.95 (0.61%). The stock has shown a trend reversal, gaining after four consecutive days of decline, although it has been trading lower than its moving averages across various time frames. Despite this recent uptick, the stock has underperformed significantly over the past year, with a return of -30.96%. Factors contributing to this performance include a high management efficiency indicated by a return on equity (ROE) of 35.83% and a low debt-to-equity ratio, but the stock is trading at a premium compared to its peers. Additionally, while institutional holdings are high at 28.67%, the company's net sales and operating profit have seen negative growth over the last five years, which raises concerns about its long-term viability.
In the broader market context, Sanofi India's short-term performance has been poor compared to the benchmark, with a one-week return of -1.22% against the Sensex's gain of +1.06%. This underperformance is further highlighted by the stock's year-to-date decline of -16.86%, while the Sensex has increased by +4.21%. The recent rise in investor participation, with a significant increase in delivery volume, may indicate some renewed interest, but the overall negative trends in sales and profits suggest that the stock's recovery may be limited in the face of broader market gains.